These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19501077)

  • 1. The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis.
    Wang J; Hu B; Meng Y; Zhang C; Li K; Hui C
    Clin Biochem; 2009 Sep; 42(13-14):1352-7. PubMed ID: 19501077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation.
    Wang J; Hu B; Kong L; Cai H; Zhang C
    Clin Chim Acta; 2008 Apr; 390(1-2):67-71. PubMed ID: 18237550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
    Sarban S; Kocyigit A; Yazar M; Isikan UE
    Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
    Yoo WH
    J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis.
    Baskol G; Demir H; Baskol M; Kilic E; Ates F; Kocer D; Muhtaroglu S
    Clin Biochem; 2005 Oct; 38(10):951-5. PubMed ID: 16055108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis.
    Vallvé JC; Paredes S; Girona J; Uliaque K; Ribalta J; Hurt-Camejo E; Masana L
    J Rheumatol; 2008 Sep; 35(9):1697-703. PubMed ID: 18634161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
    Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
    J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: implication of acute coronary events.
    Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Fuji T; Takahashi H; Iida K; Matsumoto M; Kumabe T; Sato Y; Hirayama A
    Int J Cardiol; 2009 Jun; 135(2):202-6. PubMed ID: 18614250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
    Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
    Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.